Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis

被引:1
作者
Tintore, Mar [1 ]
机构
[1] Hosp Univ Vall Hebron, Dept Neurol Neuroimmunol, Ps Vall dHebron,119-129, Barcelona 08035, Spain
关键词
multiple sclerosis; review; Sativex; spasticity; symptom management;
D O I
10.2217/nmt.15.56
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spasticity is a prevalent and troublesome symptom for people with multiple sclerosis (MS). Common instruments to measure MS spasticity include the clinician-rated (modified) Ashworth scale and the patient-rated 0-10 spasticity Numerical Rating Scale (NRS). Current opinion is that measurement of MS spasticity should incorporate the patient's perspective. Other instruments to assess spasticity-associated symptoms such as the Penn spasms frequency scale, sleep quality NRS and pain NRS can assist in tracking MS spasticity evolution and inform management choices. Worsening spasticity reduces patient autonomy, impacts negatively on quality of life and increases health resource utilization and costs. Despite the wide range of issues associated with MS spasticity, undertreatment is common and standard treatment options (physiotherapy and classical oral therapies) often fail to provide adequate symptomatic control.
引用
收藏
页码:15 / 17
页数:3
相关论文
共 16 条
[1]   Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study [J].
Arroyo, Rafael ;
Massana, Mariona ;
Vila, Carlos .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (12) :850-858
[2]  
Arroyo R, 2011, EXPERT REV PHARM OUT, V11, P205, DOI [10.1586/erp.11.6, 10.1586/ERP.11.6]
[3]   INTERRATER RELIABILITY OF A MODIFIED ASHWORTH SCALE OF MUSCLE SPASTICITY [J].
BOHANNON, RW ;
SMITH, MB .
PHYSICAL THERAPY, 1987, 67 (02) :206-207
[4]   Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: A post hoc analysis of a randomized, double-blind, placebo-controlled trial [J].
Farrar, John T. ;
Troxel, Andrea B. ;
Stott, Colin ;
Duncombe, Paul ;
Jensen, Mark P. .
CLINICAL THERAPEUTICS, 2008, 30 (05) :974-985
[5]   Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life [J].
Flachenecker, P. ;
Henze, T. ;
Zettl, U. K. .
ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (03) :154-162
[6]   Stop using the Ashworth Scale for the assessment of spasticity [J].
Fleuren, J. F. M. ;
Voerman, G. E. ;
Erren-Wolters, C. V. ;
Snoek, G. J. ;
Rietman, J. S. ;
Hermens, H. J. ;
Nene, A. V. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (01) :46-52
[7]   Symptomatic treatment of multiple sclerosis [J].
Henze, T. ;
Rieckmann, P. ;
Toyka, K. V. .
EUROPEAN NEUROLOGY, 2006, 56 (02) :78-105
[8]   Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88) [J].
Hobart, JC ;
Riazi, A ;
Thompson, AJ ;
Styles, IM ;
Ingram, W ;
Vickery, PJ ;
Warner, M ;
Fox, PJ ;
Zajicek, JP .
BRAIN, 2006, 129 :224-234
[9]  
Hutchinson B., 2008, MS FOCUS, V12, P6
[10]   Symptomatic therapy and neurorehabilitation in multiple sclerosis [J].
Kesselring, J ;
Beer, S .
LANCET NEUROLOGY, 2005, 4 (10) :643-652